Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT05182658
Status:
UNKNOWN
Last Update Posted:
2023-10-26
First Post:
2021-12-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Empagliflozin in Hypertrophic Cardiomyopathy
Sponsor:
National Institute of Cardiology, Warsaw, Poland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-21
First Submit QC Date:
None
Study First Post Date:
2022-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-24
Last Update Post Date:
2023-10-26
Last Update Post Date Type:
ACTUAL